Bioceros Announces Expansion of its Service Portfolio to include BioWa POTELLIGENT® Cells
Bioceros announces expansion of the Research License Agreement with Crucell STAR® Technology.
Prima BioMed and Bioceros announce licensing agreement for Cripto- 1 cancer immunotherapy treatment.
Bioceros appoints Mark Treherne as chairman of the Supervisory Board.
DSM and Crucell Sign Agreement with Bioceros to Serve as Pre- Approved Cell Line Generation Partner.
Crucell announces research license agreement with Bioceros on STAR technology
Dr. Bram Bout joints Bioceros accompanied by a restructuring of the management structure.
Co-operation of Bioceros and CELLution on process development in disposable bioreactors
Profibrix to enter in a research collaboration with Bioceros